evidencegaps
Primary study · included by 1 review

Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine Treatment

Caglar 2002 · CAGLAR MELTEM, TUNCEL MURAT, ALPAR REHA · Clinical Nuclear Medicine · 2002

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Caglar 2002 · Reference list; Fig. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia
High administered I131 activity (study-specific thresholds) vs Low administered I131 activity (study-specific thresholds)
OR 7.14 [2.02, 25.26]3 studiesGRADE not reported
Xerostomia
High administered I131 activity (study-specific thresholds) vs Low administered I131 activity (study-specific thresholds)
OR 4.23 [1.04, 17.15]4 studiesGRADE not reported

1 including review in total.